Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03260439
Other study ID # OMB NO: 0925-0586
Secondary ID
Status Completed
Phase N/A
First received August 18, 2017
Last updated August 21, 2017
Start date June 2014
Est. completion date December 2014

Study information

Verified date August 2017
Source University of Monastir
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

After the consent of the local ethics committee and informed consent of the parents, we conducted a prospective randomized, double-blind study, from 30 June 2014 to 31 December 2014, including one to eight year olds, ASA I or II and Programmed for circumcision.We collected 53 children in each group.


Description:

After the consent of the local ethics committee and informed consent of the parents, we conducted a prospective randomized, double-blind study, from 30 June 2014 to 31 December 2014, including one to eight year olds, ASA I or II and Programmed for circumcision. Anesthesia was induced with sevoflurane at 8% and maintained by the same agent at 2%. The children were randomized to 2 groups (n = 53 in each group) to receive 0.1% BPV non-adrenalinated 0.5% / kg on each side with either tramadol 2mg / Kg (G1: GroupBT ) Or saline serum at the same volume (G2: Group B or control). Postoperative analgesia was assessed by: the modified OPS scale at waking (H0), 1st (H1), 2nd (H2), and 24th (H24) PO hour at home, by the number of analgesic inThe hospital and at home, and by the time of the first demand analgesic.


Recruitment information / eligibility

Status Completed
Enrollment 106
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender All
Age group 1 Year to 8 Years
Eligibility Inclusion Criteria:

- ASA physical status I or II

- Were scheudled to circumcision surgery

- Performed by experenced surgeon under general anesthesia

Exclusion Criteria:

- children with full stomach

- A history of gastric reflux

- A history of cardiovascular or neuromuscular disease

- Allergies to the study drugs

Study Design


Related Conditions & MeSH terms

  • Tramadol - Anesthetics- Child - Circumcision

Intervention

Drug:
Tramadol
Children receive 0.1% BPV non-adrenalinated 0.5% / kg on each side with tramadol 2mg / Kg (G1: GroupBT ). Postoperativ analgesia was assessed by: the modified OPS scale at waking (H0), 1st (H1), 2nd (H2), and 24th (H24) PO hour at home, by the number of analgesic The hospital and home, and by the time of the first demand analgesic.
Placebo
Children receive 0.1% BPV non-adrenalinated 0.5% / kg on each side with saline serum at the same volume (G2: Group B or control). Postoperativ analgesia was assessed by: the modified OPS scale at waking (H0), 1st (H1), 2nd (H2), and 24th (H24) PO hour at home, by the number of analgesic The hospital and home, and by the time of the first demand analgesic.

Locations

Country Name City State
Tunisia University Hospital of Fattouma Bourguiba Monastir Monastir- Tunisia

Sponsors (1)

Lead Sponsor Collaborator
Leila mansali stambouli

Country where clinical trial is conducted

Tunisia, 

References & Publications (1)

Kargi E, Isikdemir A, Tokgöz H, Erol B, Isikdemir F, Hanci V, Payasli C. Comparison of local anesthetic effects of tramadol with prilocaine during circumcision procedure. Urology. 2010 Mar;75(3):672-5. doi: 10.1016/j.urology.2009.06.108. Epub 2009 Oct 24. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative analgesia Postoperative analgesia was assessed by modified OPS scale, by the number of the
number of analgesic in The hospital and home, and by the time of the first demand analgesic.
from awake until 60 min after emergence